Professor Yimin Zou and colleagues have published surprising results that reveal that RYK expression inhibits wound healing, ...

Treatment resistance and relapse in the most common type of lung cancer can be traced to a protein called agrin, according to ...

Four in every 10 cancers are preventable by lifestyle changes, and it's never to early - or too late - to start, finds ...

DES became the first identified cause of "prenatal drug-induced cancer in humans" and was subsequently banned in 1971. The ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The global vaginal specula market is on a steady growth trajectory, with the market size estimated at USD 936.0 million in 2023 and projected to grow to USD 1,301.5 million by 2033, expanding at a ...

New cervical cancer screening guidelines are now endorsed by the GNWT. Cervical cancer starts in the cervix and is usually ...

Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...

Biocon Biologics, a subsidiary of India-based Biocon Ltd, said on Thursday that U.S. FDA has approved Jobevne, a biosimilar ...

Sometimes anal cancer doesn't cause any symptoms. A doctor may instead detect the cancer visually during a colonoscopy or ...